Hutchin Hill Capital’s Elevance Health ELV Stock Holding History

Hutchin Hill Capital’s Portfolio ELV Stock Details ELV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-45,321	Closed	-$8.61M	–	482
2017 Q3	$8.61M	Sell	45,321 -4,700	-9%	-$895K	0.33%	84
2017 Q2	$9.41M	Buy	50,021 +4,700	+10%	+$844K	0.32%	70
2017 Q1	$7.5M	Sell	45,321 -11,679	-20%	-$1.86M	0.2%	109
2016 Q4	$8.2M	Buy	57,000 +2,000	+4%	+$268K	0.28%	75
2016 Q3	$6.89M	Buy	55,000 +47,100	+596%	+$6.08M	0.14%	98
2016 Q2	$1.04M	Buy	+7,900	New	+$1.08M	0.03%	337
2015 Q3	–	Sell	-29,200	Closed	-$4.79M	–	632
2015 Q2	$4.79M	Buy	+29,200	New	+$4.67M	0.12%	152
2014 Q4	–	Sell	-44,900	Closed	-$5.37M	–	595
2014 Q3	$5.37M	Buy	44,900 +28,400	+172%	+$3.26M	0.2%	93
2014 Q2	$1.78M	Buy	+16,500	New	+$1.7M	0.08%	183

Other funds holding ELV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Hutchin Hill Capital's ELV Position: Q4 2017 in Review

Hutchin Hill Capital sold out of Elevance Health (ELV) in Q4 2017, closing a stake of 45,321 shares — an estimated $8.61M sold.

Hutchin Hill Capital first reported a position in ELV in Q2 2014 and held it in 9 quarters. The position peaked at $9.41M in Q2 2017. 909 funds tracked by Wall St. Rank hold ELV as of Q4 2017.

Hutchin Hill Capital reported no remaining Elevance Health position as of Q4 2017 after selling out during the quarter.
Hutchin Hill Capital sold 45,321 Elevance Health shares in Q4 2017, an estimated $8.61M.
Hutchin Hill Capital first reported a position in Elevance Health in Q2 2014 and held it in 9 quarters.
Hutchin Hill Capital's Elevance Health position peaked at $9.41M in Q2 2017.
909 funds tracked by Wall St. Rank held Elevance Health as of Q4 2017.

Based on Hutchin Hill Capital's 13F filing for Q4 2017, filed 12 Feb 2018.